No Data
No Data
Teva Pharmaceutical Industries Insider Sold Shares Worth $903,462, According to a Recent SEC Filing
Express News | Teva Launches Spring Summer 2025 Collection; Designed for Playground Earth
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals
US FDA Accepts MedinCell, Teva's Application for Bipolar I Disorder Indication for Schizophrenia Drug
Teva Pharmaceutical Industries Options Spot-On: On February 25th, 123.86K Contracts Were Traded, With 807.52K Open Interest